Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthetic fade of MEP under remimazolam in spinal cord surgery
jRCT1051220191Recruiting
- Sponsor
- Mundipharma
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of remimazolam in Back disorder, sponsored by Mundipharma. Primary endpoint: Percentage change in MEP amplitude at 4 hours. Started Mar 2023; status: recruiting.
02
Drugs
remimazolam
03
Conditions
Back disorder
Beyond the preview
Go deeper on jRCT1051220191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051220191.